Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Fabbro

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
Oncogene|January 5, 1995
NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cellsB M Marte, D Graus-Porta, M Jeschke, et al.
Archiv Der Pharmazie|July 1, 1996
Phenylamino-pyrimidine (PAP) derivatives: a new class of potent and selective inhibitors of protein kinase C (PKC)J Zimmermann, G Caravatti, H Mett, et al.
Cancer Research|September 1, 1994
Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasmsD Fabbro, C Di Loreto, C A Beltrami, et al.
Journal of the National Cancer Institute|July 16, 1997
Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequenceA Ziegler, G H Luedke, D Fabbro, et al.
Nucleic Acids Research|September 1, 1996
In the TTF-1 homeodomain the contribution of several amino acids to DNA recognition depends on the bound sequenceD Fabbro, G Tell, A Leonardi, et al.
The Journal of Biological Chemistry|August 7, 1999
Effect of potent and selective inhibitors of the Grb2 SH2 domain on cell motilityB Gay, S Suarez, C Weber, et al.
International Journal of Cancer|May 21, 1999
Author errataT Meyer, U Regenass, D Fabbro, et al.
Anti-Cancer Drug Design|November 22, 2001
Consequences of the inhibition of Hdm2 expression in human osteosarcoma cells using antisense oligonucleotidesT Geiger, D Hüsken, J Weiler, et al.
British Journal of Cancer|March 29, 2000
Protein kinase C in human renal cell carcinomas: role in invasion and differential isoenzyme expressionR Engers, S Mrzyk, E Springer, et al.
International Journal of Cancer|November 15, 1989
Staurosporine stimulates expression of the urokinase-type (u-PA) plasminogen activator in LLC-PK1 cellsC Dierks-Ventling, J Knesel, Y Nagamine, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
Oncogene|January 5, 1995
NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cellsB M Marte, D Graus-Porta, M Jeschke, et al.
Archiv Der Pharmazie|July 1, 1996
Phenylamino-pyrimidine (PAP) derivatives: a new class of potent and selective inhibitors of protein kinase C (PKC)J Zimmermann, G Caravatti, H Mett, et al.
Cancer Research|September 1, 1994
Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasmsD Fabbro, C Di Loreto, C A Beltrami, et al.
Journal of the National Cancer Institute|July 16, 1997
Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequenceA Ziegler, G H Luedke, D Fabbro, et al.
Nucleic Acids Research|September 1, 1996
In the TTF-1 homeodomain the contribution of several amino acids to DNA recognition depends on the bound sequenceD Fabbro, G Tell, A Leonardi, et al.
The Journal of Biological Chemistry|August 7, 1999
Effect of potent and selective inhibitors of the Grb2 SH2 domain on cell motilityB Gay, S Suarez, C Weber, et al.
International Journal of Cancer|May 21, 1999
Author errataT Meyer, U Regenass, D Fabbro, et al.
Anti-Cancer Drug Design|November 22, 2001
Consequences of the inhibition of Hdm2 expression in human osteosarcoma cells using antisense oligonucleotidesT Geiger, D Hüsken, J Weiler, et al.
British Journal of Cancer|March 29, 2000
Protein kinase C in human renal cell carcinomas: role in invasion and differential isoenzyme expressionR Engers, S Mrzyk, E Springer, et al.
International Journal of Cancer|November 15, 1989
Staurosporine stimulates expression of the urokinase-type (u-PA) plasminogen activator in LLC-PK1 cellsC Dierks-Ventling, J Knesel, Y Nagamine, et al.
Pageof 17